The Effect of Cooling With a Bed Topper and Linen on Itch in Clinical Routine

Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Recruiting
CT.gov ID
NCT05460598
Collaborator
(none)
40
1
2
12
3.3

Study Details

Study Description

Brief Summary

This single-blinded (only patients blinded) study is to assess the effect of cooling beddings on itch.

The primary objective is to test whether or not the use of the cooling beddings during 3 days can add at least 20% improvement in (nocturnal) itch as measured by the 0-10 NRS in comparison to a control group that does not use the cooling beddings.

Condition or Disease Intervention/Treatment Phase
  • Other: beddings with cooling effects
  • Other: commonly used bedding
N/A

Detailed Description

Itch is the most common skin-related symptom. Staying/sleeping in a bed with a cooling properties could have a positive effect on (nocturnal) itch intensity, sleep quality and daytime performance in consequence. A mattress topper and bed linen with cooling effects that are commercially available (https://www.oba.ch/cool_gel_topper) by the OBA AG (Basel), which is the supplier of beds and bedding items of the University Hospital Basel, has been used in clinical routine. This single-blinded (only patients blinded) study is to assess the effect of cooling beddings on itch and to better rationalize the beddings 'use. No comparative data is available and the design is purely exploratory. The primary objective of this study is to test whether or not the use of the cooling beddings during 3 days can add at least 20% improvement in (nocturnal) itch as measured by the 0-10 NRS in comparison to a control group that does not use the cooling beddings.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Single-center, investigator-initiated, single-blinded, interventional, exploratory study.Single-center, investigator-initiated, single-blinded, interventional, exploratory study.
Masking:
Single (Participant)
Masking Description:
single-blinded (only patients blinded)
Primary Purpose:
Other
Official Title:
The Effect of Cooling With a Bed Topper and Linen on Itch in Clinical Routine - an Exploratory Study
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: interventional group: beddings with cooling effects

Cooling beddings: linen made of the Outlast Technology https://www.outlast.com/en/. This product is made of 100 % lyocell and utilizes phase change materials based on natural wax. When this phase change material melts, heat is extracted from the environment and stored in microcapsules called thermocules. When the body cools down, these thermocules harden again release the heat from the linen. This might help to balances the body temperature and prevent warmth-aggravated itch. - The mattress is made of polyurethane foam and designed as a "cool gel" topper to be placed onto the standard hospital mattress. Heat is also absorbed and stored into this topper. This topper is covered with an Obatex cover. It protects the "cool gel" topper from moisture and organic liquids and is made of polyamide fabric.

Other: beddings with cooling effects
beddings with cooling effects (mattress topper and bed linen)

Placebo Comparator: control group: commonly used bedding

Other: commonly used bedding
commonly used bedding

Outcome Measures

Primary Outcome Measures

  1. improvement in (nocturnal) itch [NRS ratings will be assessed every 6 hours (throughout 72 hours)]

    improvement in (nocturnal) itch as measured by the 0-10 Numeric rating Scale (NRS) (at least 2 NRS points per 24 hours to obtain a meaningful therapeutic benefit). (NRS, 0= no itch, 10= worst imaginable)

Secondary Outcome Measures

  1. Scratching activity measured by actigraph (Actigraph qGT3X-BT) on the dominant wrist [Continuously recorded throughout 72 hours]

    Comparison of the actigraphy of the interventional versus control group.to record hand movements as a surrogate marker for scratching activity and to record sleep tracking functions.

  2. Richards-Campbell-Sleep Questionnaire (RCSQ) after each of the three nights addressing the sleep quality [Assessment after each night (3 times, altogether 72 hours)]

    Sleep quality assessment by RCSQ. It consists of six items addressing "Sleep depth", "Sleep latency", "Awakenings", "Returning to sleep", "Sleep quality" and "Noise", each of which is rated on a visual analogue scales ranging from 0-100 mm. A higher value of the average score represents better sleep.

  3. Patient questionnaire (regarding lying comfort, cooling pleasantness) [One time assessment after the third night]

    Patient questionnaire regarding lying comfort, cooling pleasantness (5-point Likert scales, items "Strongly disagree", "Disagree", "Neither agree nor disagree", "Agree" and "Strongly agree")

  4. Patient questionnaire regarding cooling intensity [One time assessment after the third night]

    Patient questionnaire regarding cooling intensity (0-10/ no cooling- strongest-possible cooling).

  5. Staff questionnaire regarding time practicability [Assessment after staff shift (3 times, altogether 72 hours)]

    Staff questionnaire regarding time practicability (putting on/of the linen, weight of topper, cleaning procedure of cooling beddings) (5-point Likert scales: "Strongly disagree", "Disagree", "Neither agree nor disagree", "Agree" and "Strongly agree") after their shift.

  6. Vital signs measured by Fitbit tracker [Continuously recorded throughout 72 hours]

    On the non-dominant wrist, patients will wear a tracker (Fitbit Charge 5, Fitbit LLC, USA) to capture vital signs (e.g. heart rate, respiratory rate and skin temperature).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Mean itch intensity NRS > 5 in the past 3 days

  • Literacy and ability to read

  • Inpatient stay required for > 3 nights

Exclusion Criteria:
  • Age < 18 years

  • Illiteracy

  • Cognitive impairment (exclusion in case of mild cognitive impairment according to the Montreal-Cognitive Assessment (MOCA))

  • The duration of the hospitalisation is foreseen to be shorter than 3 days

  • Para- and Tetraplegia

  • Hemisensory syndrome

  • Core body temperature >38°C

  • Use of other bedding > 8 hours or 2nd time request

  • Use of an occlusive therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Dermatology, University Hospital Basel Basel Switzerland 4031

Sponsors and Collaborators

  • University Hospital, Basel, Switzerland

Investigators

  • Principal Investigator: Simon Mueller, PD Dr. med., Department of Dermatology, University Hospital Basel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT05460598
Other Study ID Numbers:
  • 2022-00160; th21Mueller2
First Posted:
Jul 15, 2022
Last Update Posted:
Jul 15, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Basel, Switzerland
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 15, 2022